Biotechnology - Genomic and Proteomics/Commons based cases in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
#* Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants) | #* Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants) | ||
#* Identify what actors are participating on this and what actors are just observers (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant and helpful questions) | #* Identify what actors are participating on this and what actors are just observers (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant and helpful questions) | ||
==Resources== | |||
[https://cyber.law.harvard.edu/commonsbasedresearch/Commons-based_cases_in_BGP Commons-Based Cases in BGP] | [https://cyber.law.harvard.edu/commonsbasedresearch/Commons-based_cases_in_BGP Commons-Based Cases in BGP] | ||
Revision as of 22:42, 4 March 2009
Answer the questions:
- Commons based cases (the cases that we know will appear in the right part of the quadrants)
- Identify cases
- Correlate them with their main outputs (Data. Narratives. Tools)
- How and in what extent they are “experimenting” or “adopting” commons-based approach. Are they adopting OA policies, for instance? Are they adopting Social Responsible License approaches?
- Identify these cases and treat them as entities that will also be placed in our mapping device (the quadrants)
- Identify what actors are participating on this and what actors are just observers (Use the questionnaire to guide your research when appropriate - Carol will select specific relevant and helpful questions)